💊 Olanzapine (Olanzapine)
Olanzapine is an atypical antipsychotic prescribed for schizophrenia and for manic or mixed episodes of bipolar I disorder. This leaflet covers the orally disintegrating tablet form. Your doctor determines the right dose and duration for you.
In Arabic: أولانزابين🏷️ Brand names & manufacturers
Packages shown are US-market (DailyMed). Brands available in Palestine are in the price section below.✅ What it is used for
- Treatment of schizophrenia in adults and adolescents (ages 13 to 17)
- Acute treatment of manic or mixed episodes associated with bipolar I disorder, and maintenance treatment of bipolar I disorder
- Adjunct to valproate or lithium for manic or mixed episodes in adults
- In combination with fluoxetine (Symbyax): depressive episodes associated with bipolar I disorder and treatment resistant depression
🧪 Active ingredient
The active ingredient is olanzapine, a thienobenzodiazepine. Its mechanism in the listed indications is unclear, but efficacy in schizophrenia could be mediated through a combination of dopamine and serotonin type 2 (5HT2) antagonism.
🌿 Benefits
- Reduces symptoms of schizophrenia
- Treats manic or mixed episodes and helps maintain treatment in bipolar I disorder
- Orally disintegrating form taken once daily
📝 How to use
- Taken by mouth once daily, with or without food
- The tablet begins disintegrating in the mouth within seconds and can be swallowed with or without liquid
- The dose is set by your doctor or pharmacist; do not change the dose or stop the medicine on your own
- The doctor may start with a lower dose in elderly or debilitated patients or those prone to low blood pressure
💊 Dosage forms
- Orally disintegrating tablets: 5 mg, 10 mg, 15 mg, 20 mg (yellow, round, not scored)
⚠️ Common side effects
- Adults with schizophrenia: postural hypotension, constipation, weight gain, dizziness, personality disorder, akathisia
- Adolescents: sedation, weight increase, headache, increased appetite, dizziness, abdominal pain, pain in extremity, fatigue, dry mouth
- Adults with mania: asthenia, dry mouth, constipation, increased appetite, somnolence, dizziness, tremor
- With lithium or valproate: dry mouth, weight gain, increased appetite, dizziness, back pain, constipation, speech disorder, increased salivation, amnesia, paresthesia
🚨 Serious — seek medical help
- Increased risk of death and cerebrovascular events (e.g., stroke) in elderly patients with dementia-related psychosis
- Neuroleptic malignant syndrome (requires immediate discontinuation)
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
- Hyperglycemia and diabetes mellitus (sometimes with ketoacidosis, hyperosmolar coma or death), dyslipidemia and weight gain
- Tardive dyskinesia
- Orthostatic hypotension with dizziness, tachycardia, bradycardia and sometimes syncope
- Leukopenia, neutropenia and agranulocytosis
⛔ Do not use if
- None with olanzapine monotherapy
- When used with fluoxetine, refer to the Symbyax contraindications; when used with lithium or valproate, refer to those products' labels
❗ Warnings & precautions
- Boxed warning: not approved for dementia-related psychosis; elderly patients with it have an increased risk of death
- The possibility of a suicide attempt is inherent in schizophrenia and bipolar I disorder; high-risk patients need close supervision
- Fasting blood glucose and lipids should be checked at the start of and periodically during treatment, and weight monitored regularly
- Use caution in patients with cardiovascular or cerebrovascular disease and conditions affecting hemodynamic responses
- Discontinue if clinically appropriate for tardive dyskinesia, and discontinue for neuroleptic malignant syndrome or suspected DRESS
- Adolescents have greater potential for weight gain and dyslipidemia than adults, so other drugs may be considered first
- Tablets contain aspartame
🔄 Drug interactions
- Diazepam: may potentiate orthostatic hypotension
- Alcohol: may potentiate orthostatic hypotension; use caution
- Carbamazepine: increases olanzapine clearance by approximately 50%
- Fluvoxamine: may increase olanzapine levels
- Other centrally acting drugs: use caution when combined
- Antihypertensive agents: enhanced antihypertensive effect
- Levodopa and dopamine agonists: olanzapine may antagonize their effect
- Cimetidine and aluminum/magnesium antacids: did not affect olanzapine absorption
🤰 Pregnancy
Neonates exposed to antipsychotics, including olanzapine, in the third trimester are at risk of extrapyramidal and/or withdrawal symptoms after delivery. Available epidemiologic data have not established a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes, but untreated illness also carries risks, so discuss with your doctor. A pregnancy exposure registry exists for atypical antipsychotics (1-866-961-2388).
🍼 Breastfeeding
The label text provided does not include sufficient information on breastfeeding; consult your doctor or pharmacist.
🧒 Children
Safety and effectiveness in schizophrenia and bipolar mania were established in short-term studies in adolescents 13 to 17 years, with a lower starting dose than adults. Adolescents are more likely to gain weight, experience sedation, and have greater increases in cholesterol, triglycerides, LDL, prolactin and liver aminotransferases. Safety and effectiveness in children under 13 have not been established. Treatment of pediatric patients should follow a thorough diagnostic evaluation.
👴 Older adults
Elderly patients with dementia-related psychosis have an increased risk of death and cerebrovascular events, and olanzapine is not approved for this use. A lower starting dose should be considered in geriatric patients, particularly nonsmoking women aged 65 or older.
🌡️ Storage
Store at 20°C to 25°C (excursions permitted to 15°C to 30°C). Protect from light and moisture, and keep out of reach of children.
⏰ Missed dose
The label text provided gives no specific instruction for a missed dose; ask your doctor or pharmacist and do not double the dose on your own.
🆘 Overdose
There is no specific antidote. Overdose symptoms may include agitation/aggressiveness, slurred speech, tachycardia, extrapyramidal symptoms and reduced consciousness from sedation to coma; serious reactions can occur. Seek emergency medical help immediately or contact a poison control center (1-800-222-1222 in the US).
💰 Price & brands in your area
🏛️ Official price in Palestine — Ministry of Health price list:
| Product | Company | Pack | Price |
|---|---|---|---|
| OLANZAPINE 5MG ODT (28 DISSOLVE TAB) OLANZAPINE 5MG | Teva | 28 DISSOLVES TABLETS | 82 ₪ |
| Prexolan 5MG ODT Olanzapine | Jepharm Co. | 30 ODT tablet | 85 ₪ |
| ZYPREXA 5 mg VELOTAB Olanzapine | TRANSMED PHARMA | 28 Tab | 88 ₪ |
| OLANZAPINE T.TAB 10MG OLANZAPINE | Teva | 28 TAB | 94 ₪ |
| ZYPREXA 10 mg VELOTAB Olanzapine | TRANSMED PHARMA | 28 Tab | 131 ₪ |
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Mechanism in listed indications is unclear; schizophrenia efficacy may be mediated by dopamine and serotonin 5HT2 antagonism. High affinity for 5HT2A/2C, 5HT6, D1-4, H1 and α1 receptors; moderate affinity for 5HT3 and muscarinic M1-5. Well absorbed, peak at ~6 hours, ~40% first-pass metabolism, unaffected by food. Half-life 21-54 hours (mean 30), 93% plasma protein bound. ODT and tablet forms are bioequivalent.
Labeled dosing
Adult schizophrenia: start 5-10 mg once daily, target 10 mg/day within several days; adjust at intervals of at least 1 week in 5 mg increments; not indicated above 20 mg/day. Adult mania: start 10 or 15 mg once daily (10 mg with lithium/valproate). Adolescents (schizophrenia or mania): start 2.5-5 mg, target 10 mg/day. Start at 5 mg in debilitated patients, those predisposed to hypotension, slower metabolizers (e.g., nonsmoking females ≥65) or pharmacodynamically sensitive patients. May be given without regard to meals. Bipolar depression/treatment resistant depression: only in combination with fluoxetine (adults: 5 mg olanzapine + 20 mg fluoxetine; children/adolescents: 2.5 mg + 20 mg). Final dose is determined by the prescriber.
- Olanzapine monotherapy is not indicated for depressive episodes of bipolar I disorder or treatment resistant depression
- Safety of olanzapine doses above 18 mg with fluoxetine 75 mg (adults) and above 12 mg with 50 mg (ages 10-17) has not been evaluated
- Monitor fasting glucose, lipids and weight at baseline and periodically
🎓 Key points for students
- Class: atypical antipsychotic, thienobenzodiazepine
- Main indications: schizophrenia and bipolar I disorder
- Boxed warning: increased mortality in elderly with dementia-related psychosis
- Metabolic effects: hyperglycemia, dyslipidemia, weight gain
- Interactions: carbamazepine (increases clearance), fluvoxamine (raises levels), alcohol and diazepam (orthostatic hypotension)
- Rare serious reactions: NMS, DRESS, tardive dyskinesia, agranulocytosis
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is olanzapine used for?
It treats schizophrenia and manic or mixed episodes of bipolar I disorder, and with fluoxetine it treats bipolar depressive episodes and treatment resistant depression.
Can it be taken with food?
Yes, it is taken once daily with or without food. The tablet dissolves in the mouth and can be swallowed with or without liquid.
Does olanzapine cause weight gain?
Weight gain is a common effect, so weight, blood glucose and lipids are monitored regularly; adolescents are more likely to be affected.
Can I drink alcohol while taking it?
Use caution or avoid it, because alcohol may increase the orthostatic hypotension seen with olanzapine.
Is it safe for elderly patients with dementia?
No. It is not approved for dementia-related psychosis because of an increased risk of death and cerebrovascular events.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2025-03), simplified. Updated: 2026-11-15.
Weltruza🏭 Teva Pharmaceuticals USA, Inc.
Zyprexa🏭 H2-Pharma LLC
Olanzapine Intramuscular🏭 UBI Pharma Inc.
Olanzapine🏭 Lannett Company, Inc.
Olanzapine🏭 Jubilant Cadista Pharmacuticals Inc.
Olanzapine🏭 Qilu Pharmaceutical Co., Ltd.